SCHEMBL6956211

SCHEMBL6956211

O=Cc1ccc(C(F)(F)F)cc1S(=O)(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
TSHR P16473 1/20 0.38
KMT2A Q03164 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KDM4E B2RXH2 2/20 0.38
ACP1 P24666 2/20 0.37
RAD1 O60671 1/20 0.36
P2RY6 Q15077 1/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1B1 Q16678 1/20 0.36
CES2 O00748 2/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30487705 0.83 ALOX5AP (0.41) POLBMAPTALDH1A1MEN1TSHR
SCHEMBL4556987 0.83 ALOX5AP (0.41) POLBMAPTALDH1A1MEN1TSHR
SCHEMBL16495014 0.78 HSD11B1 (0.44) MAPTALDH1A1TSHRKDM4ECA1
SCHEMBL3190051 0.77 CES2 (0.52) ALDH1A1MEN1TSHRKMT2AATM
SCHEMBL3204890 0.77 PDE2A (0.43) ALDH1A1MEN1TSHRKMT2AATM
SCHEMBL153434 0.76 CYP1A1 (0.44) POLBMAPTMEN1TSHRKMT2A
SCHEMBL9657344 0.76 RAD1 (0.41) RAD1P2RY6ENPP2
SCHEMBL6853258 0.75 POLB (0.42) POLBMAPTALDH1A1MEN1KMT2A
SCHEMBL1363127 0.75 ALDH1A1 (0.47) ALDH1A1MEN1TSHRKMT2AATM
Hydrochloric Acid SCHEMBL28320494 0.75 PDE2A (0.42) ALDH1A1MEN1TSHRKMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150247863-A1 DERIVATIVES OF 1,2-DIHYDRO-7-HYDROXYQUINOLINES CONTAINING FUSED RINGS Life Technologies Corporation 2015-09-03 US disclosed
US-20150247863-A1 DERIVATIVES OF 1,2-DIHYDRO-7-HYDROXYQUINOLINES CONTAINING FUSED RINGS Life Technologies Corporation 2015-09-03 US disclosed
US-20140356873-A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings LIFE TECHNOLOGIES CORP (US) 2014-12-04 US disclosed
US-20140356873-A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings LIFE TECHNOLOGIES CORP (US) 2014-12-04 US disclosed
US-8846925-B2 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings Life Technologies Corporation (US) 2014-09-30 US disclosed
US-8846925-B2 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings Life Technologies Corporation (US) 2014-09-30 US disclosed
US-20120315661-A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings Life Technologies Corporation (US) 2012-12-13 US disclosed
US-20120315661-A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings Life Technologies Corporation (US) 2012-12-13 US disclosed
US-8183375-B2 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings Life Technologies Corporation (US) 2012-05-22 US disclosed
US-8183375-B2 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings Life Technologies Corporation (US) 2012-05-22 US disclosed
US-20110027800-A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings Life Technologies Corporation (US) 2011-02-03 US disclosed
US-20110027800-A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings Life Technologies Corporation (US) 2011-02-03 US disclosed
US-7816519-B2 longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands Life Technologies Corporation (US) 2010-10-19 US disclosed
US-7816519-B2 longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands Life Technologies Corporation (US) 2010-10-19 US disclosed
US-20070093652-A1 longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands INVITROGEN CORPORATION (US) 2007-04-26 US disclosed
US-20070093652-A1 longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands INVITROGEN CORPORATION (US) 2007-04-26 US disclosed
US-7169922-B2 Longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond INVITROGEN CORPORATION (US) 2007-01-30 US disclosed
US-7169922-B2 Longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond INVITROGEN CORPORATION (US) 2007-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110027800-A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings CYP3A7, UGT1A7, UGT2B7 POLB 4476/4885MAPT 3476/4885ALDH1A1 45/4885
US-20070093652-A1 longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands CYP3A4, CYP3A5, UGT1A4 POLB 4565/4885MAPT 2916/4885ALDH1A1 140/4885
US-20150247863-A1 DERIVATIVES OF 1,2-DIHYDRO-7-HYDROXYQUINOLINES CONTAINING FUSED RINGS CYP3A7, UGT1A7, UGT2B7 POLB 4476/4885MAPT 3476/4885ALDH1A1 45/4885
US-20140356873-A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings CYP3A7, UGT1A7, UGT2B7 POLB 4476/4885MAPT 3476/4885ALDH1A1 45/4885
US-20120315661-A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings CYP3A7, UGT1A7, UGT2B7 POLB 4476/4885MAPT 3476/4885ALDH1A1 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.